NCDR report finds hospitals are seeing improvements but are still struggling to reach pre-COVID treatment thresholds years after pandemic precautions upended longstanding processes.

A new 57-page report from MedAxiom explored the latest data on compensation, production, staffing and medical imaging offerings among cardiology programs in the United States. 

Regardless of effectiveness or lack thereof, pandemic-response measures like masking and social distancing give many people a sense of being better off with them than without them. 

Deploying specific alerts could help health systems prescribe fewer opioids at a time when overdoses are at an all-time high. 

American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 

The new ranking, based on extensive survey data gathered by Newsweek, includes a total of 150 hospitals. Seven of the top 10 are located in the United States. 

Hospital patients who test positive for Clostridioides difficile immediately upon admission but show no symptoms are highly unlikely to spread the germ to other inpatients.

Programs managed by H-E-B, Kroger, Mark Cuban Cost Plus Drug Company and Walmart appear to offer the most options for CVD patients. When it comes to AFib and heart failure, however, researchers believe the choices could be improved.